EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic

Sara Nasser iD, Christina Fotopoulou iD, Murat Gültekin, Desislava Dimitrova, Esra Bilir iD, Gülhan Inci, Philippe Morice, Mansoor Raza Mirza, Antonio Gonzalez Martin iD, Jonathan Berek, Jalid Sehouli iD, Collaborating Groups: European Network for Gynaecological Oncology Trials (ENGOT), European Society for Gynaecological Oncology (ESGO), Gynecological Cancer In…

Archives of Gynecology and Obstetrics · 05.06.2024 · 310 (1) · 577-586

DOI: 10.1007/s00404-024-07511-4 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Gynecology and Obstetrics, online erschienen am 05.06.2024. Verfasst von Sara Nasser und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Gynecological Oncology, Charite Campus Virchow Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany. sara.nasser@char…. Hauptthemen laut MEDLINE: COVID-19, Genital Neoplasms, Female, Clinical Trials as Topic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Charité - Universitätsmedizin Berlin.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Our prospective international survey evaluated the impact of the early phase of the COVID-19 pandemic on the management gynaecological malignancies from the multidisciplinary physicians’ perspective with particular focus on clinical infrastructures and trial participation.

Methods

Our survey consisted of 53 COVID-related questions. It was sent to healthcare professionals in gynaecological oncology centres across Europe and Pan-Arabian region via the study groups and gynaecological societies from April 2020 to October 2020. All healthcare professionals treating gynaecological cancers were able to participate in our survey.

Results

A total of 255 answers were collected from 30 countries. The majority (73%) of participants were gynaecological oncologists from university hospitals (71%) with at least an Intensive Care Unit with cardiopulmonary support available at their institutions. Most institutions continued to perform elective surgeries only for oncological cases (98%). Patients had to wait on average 2 weeks longer for their surgery appointments compared to previous years (range 0–12 weeks). Most cases that were prioritised for surgical intervention across all gynaecological tumours were early-stage disease (74%), primary situation (61%) and good ECOG status (63%). The radicality of surgery did not change in the majority of cases (78%) across all tumour types. During the pandemic, only 38% of clinicians stated they would start a new clinical trial. Almost half of the participants stated the pandemic negatively impacted the financial structure and support for clinical trials. Approximately 20% of clinicians did not feel well-informed regarding clinical algorithm for COVID-19 patients throughout the pandemic. Thirty percent stated that they are currently having trouble in providing adequate medical care due to staff shortage.

Conclusion

Despite well-established guidelines, pandemic clearly affected clinical research and patientcare. Our survey underlines the necessity for building robust emergency algorithms tailored to gynaecological oncology to minimise negative impact in crises and to preserve access to clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Genital Neoplasms, FemaleClinical Trials as TopicHumansFemaleSARS-CoV-2Prospective StudiesHealth Services AccessibilitySurveys and QuestionnairesMedical OncologyGynecologyPatient CarePandemics

Stichwörter der Autor:innen

COVID-19Clinical trialsGynaecologic oncologyHealthcare disparitiesPandemic

Autor:innen und Institutionen

  • Department of Gynecology and Gynecological Oncology, Charite Campus Virchow Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany. sara.nasser@charite.de.
  • Department of Gynecology and Gynecological Oncology, Charite Campus Virchow Klinikum, Augustenburgerplatz 1, 13353, Berlin, Germany.
  • Department of Gynecological Oncology, Queen Charlotte's Hospital, Imperial College London, London, UK.
  • Department of Gynecology and Obstetrics, Hacettepe University Hospitals, Ankara, Turkey.
  • Department of Global Health, Koç University Graduate School of Health Sciences, Istanbul, Turkey.
  • Department of Obstetrics and Gynecology, University Hospitals Schleswig-Holstein, Campus Kiel, Kiel, Germany.

ORCID-Profile: Sara Nasser, Christina Fotopoulou, Esra Bilir, Antonio Gonzalez Martin, Jalid Sehouli

Förderung

  • Charité - Universitätsmedizin Berlin

Zitieren

APA

Nasser, S., Fotopoulou, C., Gültekin, M., Dimitrova, D., Bilir, E., Inci, G., Morice, P., Mirza, M. R., Martin, A. G., Berek, J., Sehouli, J., & Collaborating Groups: European Network for Gynaecological Oncology Trials (ENGOT), European Society for Gynaecological Oncology (ESGO), Gynecological Cancer In… (2024). Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic. Archives of Gynecology and Obstetrics, 310(1), 577-586. https://doi.org/10.1007/s00404-024-07511-4

Vancouver

Nasser S, Fotopoulou C, Gültekin M, Dimitrova D, Bilir E, Inci G, et al. Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic. Archives of Gynecology and Obstetrics. 2024;310(1):577-586. doi:10.1007/s00404-024-07511-4

BibTeX
@article{Nasser2024,
  author = {Nasser, Sara and Fotopoulou, Christina and Gültekin, Murat and Dimitrova, Desislava and Bilir, Esra and Inci, Gülhan and Morice, Philippe and Mirza, Mansoor Raza and Martin, Antonio Gonzalez and Berek, Jonathan and Sehouli, Jalid and Collaborating Groups: European Network for Gynaecological Oncology Trials (ENGOT), European Society for Gynaecological Oncology (ESGO), Gynecological Cancer In…, Collaborating Groups: European Network for Gynaecological Oncology Trials (ENGOT), European Society for Gynaecological Oncology (ESGO), Gynecological Cancer In…},
  title = {Patient care and access to clinical trials in gynaecological oncology: global implications of the early phase of the COVID-19 pandemic},
  journal = {Archives of Gynecology and Obstetrics},
  year = {2024},
  volume = {310},
  number = {1},
  pages = {577--586},
  doi = {10.1007/s00404-024-07511-4}
}
Kostenlos starten →